Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 272 M234 M277 M308 M 1.09 B Research & development 240 M247 M229 M239 M 955 M Operating income 209 M214 M227 M202 M 852 M Non-Operating Income, Total -52 M92 M-7 M176 M 209 M Interest expense, net of interest capitalized 24 M25 M25 M26 M 100 M Non-Operating Income, excl. Interest Expenses -13 M-15 M-16 M-16 M -60 M Unusual income/expense -39 M107 M9 M192 M 269 M Pretax income 157 M306 M220 M378 M 1.06 B Equity in earnings ———— — Taxes 23 M71 M70 M44 M 208 M Non-controlling/minority interest ———— — After tax other income/expense -8 M-11 M-9 M0 -28 M Net income before discontinued operations 134 M235 M150 M334 M 853 M Discontinued operations ———— — Net income 134 M235 M150 M334 M 853 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 134 M235 M150 M334 M 853 M Basic earnings per share (Basic EPS) 0.881.490.982.17 5.52 Diluted earnings per share (Diluted EPS) 0.871.490.982.16 5.5 Average basic shares outstanding 153 M157 M153 M155 M — Diluted shares outstanding 154 M157 M154 M156 M — EBITDA 295 M282 M294 M268 M 1.14 B EBIT 209 M214 M227 M202 M 852 M Cost of revenue 370 M364 M351 M400 M 1.49 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 86 M68 M67 M66 M 287 M